title: Latanoprost therapy in patients with glaucoma and ocular hypertension inadequately controlled with carteolol.
authors.forename: Tekin
authors.initials: T
authors.lastname: Yasar
authors.forename: Murat
authors.initials: M
authors.lastname: Ozdemir
authors.forename: Inayet
authors.initials: I
authors.lastname: Andi
authors.forename: Gokhan
authors.initials: G
authors.lastname: Ozdemir
authors.forename: Saban
authors.initials: S
authors.lastname: Simsek
mesh_terms: D000328:Adult; D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use*; D002354:Carteolol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005260:Female; D005902:Glaucoma, Open-Angle / Q000188:drug therapy*; D006801:Humans; D007429:Intraocular Pressure / Q000187:drug effects; D000077338:Latanoprost; D008297:Male; D008875:Middle Aged; D009798:Ocular Hypertension / Q000188:drug therapy; D010349:Patient Compliance; D011461:Prostaglandins F, Synthetic / Q000627:therapeutic use*
chemical_list: D000959:Antihypertensive Agents; D011461:Prostaglandins F, Synthetic; D000077338:Latanoprost; D002354:Carteolol